時間 | 主題 | ||||
---|---|---|---|---|---|
15:20 ~ 15:40 |
瀏覽海報時間
講者:
All
座長:
張延驊, 黃冠華 |
All |
張延驊, 黃冠華 |
||
MP02-1: Outcome of robotic radical prostatectomy for locally advanced prostate cancer (≥ pT3 or N1)
講者:
李柏毅
座長:
張延驊, 黃冠華 |
李柏毅 |
張延驊, 黃冠華 |
|||
MP02-2: Detection of circulating tumor cells in patients with penile squamous cell carcinoma: A preliminary study
講者:
江佩璋
座長:
張延驊, 黃冠華 |
江佩璋 |
張延驊, 黃冠華 |
|||
MP02-3: Preoperative monocyte-to-lymphocyte ratio as a non-invasive diagnostic tool for prediction of renal cell carcinoma and oncocytoma in patients with renal tumor
講者:
林于巧
座長:
張延驊, 黃冠華 |
林于巧 |
張延驊, 黃冠華 |
|||
MP02-4: Metastatic urothelial carcinoma patients treated with immune checkpoint inhibitor based immunotherapy
講者:
陳韋辰
座長:
張延驊, 黃冠華 |
陳韋辰 |
張延驊, 黃冠華 |
|||
MP02-5: Immune checkpoint inhibitors (ICIs) in end-stage renal disease (ESRD) patients with metastatic urothelial carcinoma (mUC)
講者:
黃英哲
座長:
張延驊, 黃冠華 |
黃英哲 |
張延驊, 黃冠華 |
|||
MP02-6: Nivolumab (NIVO) in pretreated patients with metastatic renal cell carcinoma (mRCC), a single hospital experience
講者:
倪雪雰
座長:
張延驊, 黃冠華 |
倪雪雰 |
張延驊, 黃冠華 |
|||
MP02-7: Increased cardiovascular risk after androgen deprivation therapies among newly diagnosed prostate cancer patients
講者:
謝享宸
座長:
張延驊, 黃冠華 |
謝享宸 |
張延驊, 黃冠華 |
|||
MP02-8: Comparation between penoscrotal approach with perineal approach for artificial sphincter implantation in male urinary incontinence
講者:
江品葭
座長:
張延驊, 黃冠華 |
江品葭 |
張延驊, 黃冠華 |
|||
MP02-9: The incidence of urethral stricture and bladder neck stricture between bipolar and monopolar transurethral resection of prostate
講者:
劉品均
座長:
張延驊, 黃冠華 |
劉品均 |
張延驊, 黃冠華 |
|||
MP02-10: Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate
講者:
陳柏翰
座長:
張延驊, 黃冠華 |
陳柏翰 |
張延驊, 黃冠華 |